Literature DB >> 23089356

Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death.

Paola Conforti1, Stefano Camnasio, Cesare Mutti, Marta Valenza, Morgan Thompson, Elisa Fossale, Scott Zeitlin, Marcy E MacDonald, Chiara Zuccato, Elena Cattaneo.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder that affects muscle coordination and diminishes cognitive abilities. The genetic basis of the disease is an expansion of CAG repeats in the Huntingtin (Htt) gene. Here we aimed to generate a series of mouse neural stem (NS) cell lines that carried varying numbers of CAG repeats in the mouse Htt gene (Hdh CAG knock-in NS cells) or that had Hdh null alleles (Hdh knock-out NS cells). Towards this end, Hdh CAG knock-in mouse ES cell lines that carried an Htt gene with 20, 50, 111, or 140 CAG repeats or that were Htt null were neuralized and converted into self-renewing NS cells. The resulting NS cell lines were immunopositive for the neural stem cell markers NESTIN, SOX2, and BLBP and had similar proliferative rates and cell cycle distributions. After 14 days in vitro, wild-type NS cells gave rise to cultures composed of 70% MAP2(+) neurons and 30% GFAP(+) astrocytes. In contrast, NS cells with expanded CAG repeats underwent neuronal cell death, with only 38%±15% of the MAP2(+) cells remaining at the end of the differentiation period. Cell death was verified by increased caspase 3/7 activity on day 14 of the neuronal differentiation protocol. Interestingly, Hdh knock-out NS cells treated using the same neuronal differentiation protocol showed a dramatic increase in the number of GFAP(+) cells on day 14 (61%±20% versus 24%±10% in controls), and a massive decrease of MAP2(+) neurons (30%±11% versus 64%±17% in controls). Both Hdh CAG knock-in NS cells and Hdh knock-out NS cells showed reduced levels of Bdnf mRNA during neuronal differentiation, in agreement with data obtained previously in HD mouse models and in post-mortem brain samples from HD patients. We concluded that Hdh CAG knock-in and Hdh knock-out NS cells have potential as tools for investigating the roles of normal and mutant HTT in differentiated neurons and glial cells of the brain.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089356     DOI: 10.1016/j.nbd.2012.10.015

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  18 in total

1.  Deficits in adult neurogenesis, contextual fear conditioning, and spatial learning in a Gfap mutant mouse model of Alexander disease.

Authors:  Tracy L Hagemann; Richard Paylor; Albee Messing
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

2.  Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation.

Authors:  Marta Biagioli; Francesco Ferrari; Eric M Mendenhall; Yijing Zhang; Serkan Erdin; Ravi Vijayvargia; Sonia M Vallabh; Nicole Solomos; Poornima Manavalan; Ashok Ragavendran; Fatih Ozsolak; Jong Min Lee; Michael E Talkowski; James F Gusella; Marcy E Macdonald; Peter J Park; Ihn Sik Seong
Journal:  Hum Mol Genet       Date:  2015-01-08       Impact factor: 6.150

Review 3.  Modeling Huntington's disease with induced pluripotent stem cells.

Authors:  Julia A Kaye; Steven Finkbeiner
Journal:  Mol Cell Neurosci       Date:  2013-02-28       Impact factor: 4.314

4.  Experimental models for identifying modifiers of polyglutamine-induced aggregation and neurodegeneration.

Authors:  Barbara Calamini; Donald C Lo; Linda S Kaltenbach
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

5.  Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.

Authors:  Wojciech J Szlachcic; Pawel M Switonski; Wlodzimierz J Krzyzosiak; Marek Figlerowicz; Maciej Figiel
Journal:  Dis Model Mech       Date:  2015-06-18       Impact factor: 5.758

6.  Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis.

Authors:  Giang D Nguyen; Solen Gokhan; Aldrin E Molero; Mark F Mehler
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

7.  Inhibition of Sox2 Expression in the Adult Neural Stem Cell Niche In Vivo by Monocationic-based siRNA Delivery.

Authors:  Sylvie Remaud; Silvia Alejandra López-Juárez; Anne-Laure Bolcato-Bellemin; Patrick Neuberg; Fabrice Stock; Marie-Elise Bonnet; Rym Ghaddab; Marie Stéphanie Clerget-Froidevaux; Jacqueline Pierre-Simons; Patrick Erbacher; Barbara A Demeneix; Ghislaine Morvan-Dubois
Journal:  Mol Ther Nucleic Acids       Date:  2013-04-23       Impact factor: 10.183

8.  Functions of huntingtin in germ layer specification and organogenesis.

Authors:  Giang D Nguyen; Aldrin E Molero; Solen Gokhan; Mark F Mehler
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

9.  Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease.

Authors:  M Valenza; M Marullo; E Di Paolo; E Cesana; C Zuccato; G Biella; E Cattaneo
Journal:  Cell Death Differ       Date:  2014-10-10       Impact factor: 15.828

Review 10.  Huntington's disease: the past, present, and future search for disease modifiers.

Authors:  Erin B D Clabough
Journal:  Yale J Biol Med       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.